Clinical Scorecard: Response to ADHD Treatment in Adult Women with Autism Spectrum Disorder and Suicidal Behavior – Three Individual Cases

At a Glance

Key Highlights

• Suicidality and self-harm are significantly higher in females with ASD, especially those with comorbid untreated ADHD.
• ADHD treatment in females with ASD and suicidality leads to rapid improvements in mood, suicidality, and coping skills.
• Females with ASD often remain undiagnosed or diagnosed late due to camouflaging and atypical presentations.

Guideline-Based Recommendations

Diagnosis

• Screen for ADHD and ASD in females presenting with suicidality, especially in atypical or treatment-resistant cases.
• Use DSM-5 or DSM-5-TR criteria and Adult ADHD Self-Report Rating Scale for diagnosis.
• Consider executive function deficits and impulsivity as key diagnostic features.

Management

• Initiate ADHD pharmacologic treatment to improve executive functions and reduce impulsivity.
• Taper antidepressants and antipsychotics as ADHD treatment leads to clinical improvement.
• Monitor and manage side effects of ADHD medications carefully.

Monitoring & Follow-up

• Assess suicidality regularly during ADHD treatment.
• Monitor mood, coping skills, and executive function improvements.
• Track emergency department visits and psychiatric admissions.

Risks

• Delayed diagnosis of ASD and ADHD increases suicide risk.
• Prior maltreatment, cognitive inflexibility, social isolation, and camouflaging behaviors elevate suicidality risk.
• ADHD medication side effects may occur and require vigilance.

Patient & Prescribing Data

Young adult females with ASD and comorbid ADHD exhibiting recurrent suicidality and serious mental illness.

ADHD medications produced remarkable clinical improvement in mood and suicidality, enabling reduction of other psychotropics; side effects were notable in some cases.

Clinical Best Practices

• Include ADHD and ASD screening in suicidality assessments, especially for females with atypical presentations.
• Recognize executive dysfunction and impulsivity as modifiable risk factors for suicidality.
• Use a multidisciplinary approach to manage comorbid ASD and ADHD with suicidality.
• Educate patients on coping skills enhanced by ADHD treatment.
• Obtain informed consent and follow ethical guidelines for case reporting.

References

• CDC ASD Prevalence Data 2022
• DSM-5-TR Diagnostic Criteria
• Adult ADHD Self-Report Scale (ASRS)
• CARE Guidelines for Case Reports
• National Center for Health Statistics Suicide Data 2022